Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03021759 · ClinicalTrials.gov registry record · NA
Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 4,774
- Enrollment target
NCT03021759: Completed NA study, sponsored by University of Pennsylvania.
NCT03021759 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 4,774 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03021759, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,774 participants
- Enrollment target
Study Summary
In this study, the investigators will conduct a pragmatic, cluster-randomized, controlled trial to evaluate an active choice intervention with and without social comparison feedback to increase physician statin prescribing rates for eligible patients.
Interventions
- BEHAVIORAL Active choice
- BEHAVIORAL Social comparison feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,774 participants |
| Start Date | 2017-02-21 |
| Est. Completion | 2017-04-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03021759
The ClinicalTrials.gov registry entry for NCT03021759 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4,774 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active choice is the first listed.
NCT03021759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03021759 about?
NCT03021759 is a clinical study titled "Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence". In this study, the investigators will conduct a pragmatic, cluster-randomized, controlled trial to evaluate an active choice intervention with and without social comparison feedback to increase physician statin prescribing rates for eligible patients.
What is the current status of trial NCT03021759?
This trial is currently completed. It is a NA study. The enrollment target is 4,774 participants. The study started on 2017-02-21. Estimated completion is 2017-04-21.
What interventions are being tested in trial NCT03021759?
The interventions under investigation include: Active choice (BEHAVIORAL), Social comparison feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT03021759?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.